NCT04169100View on ClinicalTrials.gov

Novel Form of Acquired Long QT Syndrome

PHASE4UnknownINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 28, 2011

Primary Completion Date

March 31, 2024

Study Completion Date

September 30, 2024

Conditions
Long QT SyndromeConnective Tissue DiseasesRheumatoid Arthritis
Interventions
DRUG

Prednisone

We propose to test whether QT prolongation is reversible with moderate doses of prednisone in patients with QT interval greater than 500 msec.

Trial Locations (1)

11209

RECRUITING

VA New York Harbor Healthcare System, NY and Brooklyn Campuses, New York

Sponsors
All Listed Sponsors
collaborator

VA New York Harbor Healthcare System

FED

lead

Narrows Institute for Biomedical Research

OTHER